The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
Mpox, formally known as Monkeypox, cases are on the rise ... meaning they either never received a vaccine, or they only got one dose," Dr. Jenni McQuiston, deputy director of the CDC's high ...
At one dose, the vaccine was found to be 75.2% effective. Back in 2022, when initial supplies were constrained, the FDA issued an emergency use authorization (EUA) allowing intradermal ...
Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
The 1.5 mg and 4.5 mg doses of Trulicity, another diabetes drug by Lilly, will also be available in limited amounts through April due to increased demand, according to the FDA's website.
The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate ... as 2 doses 6 months apart ...
Labcorp (LH) receives FDA emergency use authorization for its Mpox PCR Test Home Collection Kit, which can detect the ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...
The Food and Drug Administration said Thursday that traces of the bird flu virus have been found in 1 in 5 samples of ...